Stay updated with breaking news from Fleming Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Private equity firm InvAscent plans to list five portfolio companies in the health and pharmaceutical sectors over the next 24–36 months, providing exit opportunities for the investor.
Fleming is a backward integrated API manufacturer with global leadership in select muscle relaxant, anti-arthritis, and antihistamine APIs with two regulatory-approved manufacturing units. The company sells to customers in over 65 countries across Latin America, Europe, Asia, and MENA.
Homegrown healthcare-focussed private equity firm InvAscent has hit the first close for its latest fund, even as it struck a fresh investment in an active ......